Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...

Linda Yaccarino, a prominent figure in the media industry, has been appointed as the new CEO of EMed, a company focused on ...

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social ...

The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.

EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced the members of its Scientific Advisory Board (SAB). Established in 1991, EMED Technologies is a ...

Just a month after her exit from Musk's X, the tech executive will lead the digital platform for GLP-1 health management ...